INM vs IRWD Valuation Comparison 2026 — Intrinsic Value Analysis

Quick Summary — IRWD scores higher on quality with 7.7/10 vs INM's 5.0/10. INM trades at $1.52 while IRWD trades at $3.28. Both analyzed daily using SEC EDGAR data across 13 institutional models.

INM

Drug Manufacturers - Specialty & Generic

InMed Pharmaceuticals Inc.

Quality

5.0

out of 10

Value Trap

24

SAFE

Price

$1.52

Last close

Models

11/13

Active

VS

IRWD

Drug Manufacturers - Specialty & Generic

Ironwood Pharmaceuticals, Inc.

Quality

7.7

out of 10

Value Trap

39

LOW

Price

$3.28

Last close

Models

11/13

Active

INM

Earnings Power Value sees +452.9% upside

Quality 5.0/10 — below average

IRWD

Earnings Power Value sees +70.1% upside

Limited to 2/13 visible models

INM vs IRWD — Fair Value Comparison

INM

IRWD

Market Price Model 1 Model 2

Model-by-Model Comparison

Model	Type	INM Fair Value	INM Upside	IRWD Fair Value	IRWD Upside
Bayesian DCF	Intrinsic	$1.17	-23.2%	—	—
Earnings Power Value	Intrinsic	$3.95	+452.9%	$5.58	+70.1%
EROIC Spread	Intrinsic	$0.03	-98.3%	$4.81	+46.8%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

INM vs IRWD — Which Stock Is More Undervalued in 2026?

IRWD scores higher with a 7.7/10 quality rating vs INM's 5.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

How Do INM and IRWD Valuations Compare?

INM currently trades at $1.52 while IRWD trades at $3.28. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily for both companies.

Quality of Company: INM vs IRWD

INM earns a Quality of Company score of 5.0/10 compared to IRWD's 7.7/10. This moderate difference suggests one company has an edge in fundamental quality, though both may offer investment merit depending on valuation. The QOC score synthesizes 32 signals spanning profitability margins, revenue growth, free cash flow, capital allocation, and leverage.

Value Trap Risk: INM vs IRWD

INM carries a SAFE value trap risk (24/100) while IRWD shows LOW risk (39/100). Both companies show manageable value trap risk, suggesting their current valuations are not artificially depressed by fundamental deterioration.

Both in Drug Manufacturers - Specialty & Generic

Both INM and IRWD operate in Drug Manufacturers - Specialty & Generic, which has 79 stocks tracked by CirclFi. Same-industry comparisons provide the most direct insight into relative valuation since both companies face similar regulatory environments, market dynamics, and competitive pressures. Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN), and ensemble methods (CUCE).

2 of 13 MODELS UNLOCKED

You’re comparing 2 models. 11 more have an opinion.

11 hidden models compare INM vs IRWD differently — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more. Some may disagree with the 2 you see above.

11 additional fair values per stock Full confidence breakdown Live terminal — 5,000+ stocks

Bloomberg Terminal: ~$2,000/mo · FactSet: ~$1,000/mo · CirclFi: $0.90/day

See All 13 Models — $0.90/day

We don’t predict prices. We show you what 13 independent mathematical frameworks say a stock is worth — and let you decide.

INM

View Full InMed Pharmaceuticals Inc. Analysis →

IRWD

View Full Ironwood Pharmaceuticals, Inc. Analysis →

See all Drug Manufacturers - Specialty & Generic stocks →